NCT06644300View on ClinicalTrials.gov

Study of BM230 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Solid Tumor

Interventions

DRUG

BM230

SC injection

DRUG

BM230

SC injection

Trial Locations (1)

4101

RECRUITING

Icon Cancer Centre - South Brisbane, Brisbane

All Listed Sponsors

lead

Suzhou Biomissile Pharmaceuticals Co., Ltd.

INDUSTRY